Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results
March 25, 2020 16:05 ET
|
Exagen, Inc.
SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer
March 24, 2020 08:25 ET
|
Exagen, Inc.
SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen to Announce Fourth Quarter and Year-End 2019 Financial Results on March 25, 2020
March 11, 2020 08:25 ET
|
Exagen, Inc.
SAN DIEGO, March 11, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen to Present at Cowen and Company 40th Annual Healthcare Conference
February 18, 2020 08:25 ET
|
Exagen, Inc.
SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
United Rheumatology Launches a First-of-its-Kind Outcomes Based Contract in Rheumatoid Arthritis
February 05, 2020 12:15 ET
|
United Rheumatology
Hauppauge, New York, Feb. 05, 2020 (GLOBE NEWSWIRE) -- United Rheumatology, a rheumatology management services organization, has announced a new pilot program for members of the organization. In a...
United Rheumatology Member-Adopted Clinical Pathways are Designed for Lower Cost and Higher Patient Satisfaction
January 28, 2020 10:54 ET
|
United Rheumatology
Hauppauge, New York, Jan. 28, 2020 (GLOBE NEWSWIRE) -- United Rheumatology (UR), the largest rheumatologist membership organization in the nation, is reaping the benefits of its member-drafted and...
Global Autoimmune Treatment Market is Expected to Reach USD 7.95 Billion by 2025 : Fior Markets
January 27, 2020 18:00 ET
|
Fior Markets
Newark, NJ, Jan. 27, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global autoimmune treatment market is expected to grow from USD 3.28 Billion in 2017 to USD 7.95...
Global Auto Injectors Market is Expected to Reach USD 172.38 Billion by 2025 : Fior Markets
January 27, 2020 07:00 ET
|
Fior Markets
Newark, NJ, Jan. 27, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global auto injectors market is expected to grow from USD 27.82 Billion in 2017 to USD 172.38 Billion...
Rheumatoid Arthritis Drugs Market To Reach USD 36.11 Billion By 2027 | Reports And Data
January 23, 2020 10:00 ET
|
Reports and Data
New York, Jan. 23, 2020 (GLOBE NEWSWIRE) -- The global Rheumatoid Arthritis Drugs Market is forecast to reach USD 36.11 Billion by 2027, according to a new report by Reports and Data. Rheumatoid...
Exagen Announces Addition to Russell 3000® and 2000® Indexes
December 16, 2019 08:25 ET
|
Exagen, Inc.
SAN DIEGO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...